We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$229M
Cap. Flow %
-1.35%
Top 10 Hldgs %
33.75%
Holding
1,490
New
144
Increased
706
Reduced
317
Closed
73

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$448M
2
AMT icon
American Tower
AMT
+$132M
3
HIW icon
Highwoods Properties
HIW
+$92.2M
4
WELL icon
Welltower
WELL
+$79.2M
5
PLD icon
Prologis
PLD
+$71.1M

Sector Composition

Rank Sector Weight
1 Real Estate 60.4%
2 Technology 9.49%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONON icon
1401
On Holding
ONON
$12.6B
-113
Closed -$3K
OVID icon
1402
Ovid Therapeutics
OVID
$440M
$0 ﹤0.01%
119
PBYI icon
1403
Puma Biotechnology
PBYI
$406M
$0 ﹤0.01%
87
PLTK icon
1404
Playtika
PLTK
$1.51B
-18,500
Closed -$511K
PRGO icon
1405
Perrigo
PRGO
$1.43B
-13,060
Closed -$618K
RDHL
1406
Redhill Biopharma
RDHL
$4.44M
0
RDWR icon
1407
Radware
RDWR
$1.19B
-2,321
Closed -$78K
RNR icon
1408
RenaissanceRe
RNR
$13.9B
-2,377
Closed -$331K
SAM icon
1409
Boston Beer
SAM
$1.93B
-436
Closed -$222K
SLE icon
1410
Super League Enterprise
SLE
$4.47M
-1
Closed -$39K
SOFI icon
1411
PUT
SoFi Technologies
SOFI
$21.5B
-3,000
Closed -$174K
SOHU
1412
Sohu.com
SOHU
$346M
-4,001
Closed -$83K
SYRE icon
1413
Spyre Therapeutics
SYRE
$8.68B
$0 ﹤0.01%
4
TALK icon
1414
Talkspace
TALK
$873M
-47,081
Closed -$172K
TCRT icon
1415
Alaunos Therapeutics
TCRT
$4.64M
$0 ﹤0.01%
3
TX icon
1416
Ternium
TX
$9.68B
-70
Closed -$3K
TXMD icon
1417
TherapeuticsMD
TXMD
$23.8M
$0 ﹤0.01%
12
UBX
1418
DELISTED
Unity Biotechnology
UBX
-12
Closed
URGN icon
1419
UroGen Pharma
URGN
$1.99B
$0 ﹤0.01%
48
VOYA icon
1420
Voya Financial
VOYA
$9.07B
-6,150
Closed -$378K
VYGR icon
1421
Voyager Therapeutics
VYGR
$184M
-82
Closed
VYNE icon
1422
VYNE Therapeutics
VYNE
$19.1M
0
WSM icon
1423
Williams-Sonoma
WSM
$27.8B
-4,900
Closed -$434K
WVE icon
1424
Wave Life Sciences
WVE
$1.13B
$0 ﹤0.01%
99
XBIT icon
1425
XBiotech
XBIT
$69.2M
-64
Closed -$1K

Similar funds

Daiwa Securities Group's Q4 2021 Portfolio in Review

As of Q4 2021, Daiwa Securities Group held 1,490 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q4 2021 filing shows 144 new, 706 increased, 317 reduced and 73 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M. The largest sale was VEREIT, Inc., an estimated $434M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2021 buy was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M.
  • Daiwa Securities Group added most to Realty Income in Q4 2021, an estimated $448M increase.
  • Daiwa Securities Group's biggest Q4 2021 reduction was CyrusOne Inc Common Stock, cutting an estimated $386M.
  • Daiwa Securities Group fully exited VEREIT, Inc. in Q4 2021, selling an estimated $434M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $17B portfolio in Q4 2021.
  • Daiwa Securities Group opened 144 new positions and closed 73 in Q4 2021.
  • Daiwa Securities Group's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.